期刊文献+

羧胺三唑抑制肿瘤细胞诱导的巨噬细胞中肿瘤坏死因子-α的释放 被引量:2

Carboxyamidotriazole inhibits the tumor necrosis factor-α secretion from the tumor cells-induced macrophages
下载PDF
导出
摘要 目的观察体外培养的肿瘤细胞对巨噬细胞炎症因子——肿瘤坏死因子-α(TNF-α)的诱导作用;初步探索羧胺三唑(CAI)对肿瘤诱导的巨噬细胞中TNF-α释放的影响。方法利用transwell装置,建立Lewis肺癌细胞(LLC)与RAW264.7巨噬细胞共培养体系,采用荧光定量PCR方法和ELISA方法分别分析RAW264.7中TNF-α的表达和释放;用LLC条件培养基(LCM)诱导RAW264.7,同时给予CAI处理,采用CCK-8方法分析LCM和CAI对RAW264.7活力的影响,采用ELISA方法分析CAI对诱导后的RAW264.7中TNF-α释放的影响。结果与LLC共培养24 h可显著增加RAW264.7中TNF-α相对表达量[单独培养vs共培养,(1.00±0.12)vs(2.23±0.17),P<0.01]和释放[单独培养vs共培养,(65.21±12.76)vs(143.92±19.22)pg/ml,P<0.05];LCM和CAI在1 h和4 h对RAW264.7活力没有影响,CAI可以显著抑制LCM对RAW264.7中TNF-α释放的诱导(4 h,P<0.01)。结论 LLC肿瘤微环境可以诱导RAW264.7中TNF-α的表达增加;CAI对这种诱导的抑制使其在肿瘤环境中表现出一定的抗炎作用,可能是其抗肿瘤作用的机制之一。 Objective To investigate the tumor necrosis factor-α(TNF-α) expression and secretion enhancement in macrophages induced by tumor cells in vitro, as well as the inhibitory effect of carboxyamidotriazole (CAI) on TNF-α induction in tumor-educated macrophages. Methods The Lewis lung carcinoma (LLC) cells and RAW264.7 macrophages were co-cultured with the transwell inserts, LLC conditioned medium (LCM) was also used to induce RAW264.7 with or without CAI treatment. Real time RT-PCR and ELISA methods were applied to analyze the TNF-αexpression and secretion in RAW264.7, respectively. CCK-8 was applied to determine the effect of LLC (LCM) and CAI on the viability of RAW264.7. Results TNF-αexpression [cultured alone vs co-cultured, (1.00 ± 0.12) vs (2.23 ± 0.17), P〈0.01] and secretion [cultured alone vs co-cultured, (65.21 ± 12.76) vs (143.92 ± 19.22) pg/ml, P〈0.05] were greatly increased in RAW264.7 after being co-cultured with LLC for 24 hours. LCM and CAI did not influence the viability of RAW264.7 at 1 hour and 4 hour, while CAI inhibited TNF-αsecretion in RAW264.7 induced by LCM (4 h, P〈0.01). Conclusion LLC tumor environment can greatly enhance the TNF-α expression in RAW264.7. CAI inhibits this induction significantly and shows anti-inflammation activity in tumor environment, which may contribute to its anti-cancer effects.
出处 《中国医药生物技术》 2014年第2期124-128,共5页 Chinese Medicinal Biotechnology
基金 "十二五"国家科技重大专项(2014ZX09507003-003) 国家自然科学基金(81201728) 高等学校博士学科点专项科研基金新教师类(20121106120019)
关键词 肿瘤坏死因子 α 巨噬细胞 共培养 羧胺三唑 Tumor necrosis factor-alpha Macrophages Co-culture Carboxyamidotriazole
  • 相关文献

参考文献15

  • 1Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorld Journal, 2011, 11:2391-2402. 被引量:1
  • 2Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, et al. Classical and alterative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunology, 2006, 211(6-8):487-501. 被引量:1
  • 3Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature, 2008, 454(7203):436-444. 被引量:1
  • 4Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev, 2002, 13(2):135-141. 被引量:1
  • 5Lambert PA, SomersKD, Kohn EC, et al. Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery, 1997, 122(2):372-378. 被引量:1
  • 6Perabo FG, Wirger A, Kamp S, et al. Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. Anticancer Res, 2004, 24(5A):2869-2877. 被引量:1
  • 7Guo L, Li ZS, Wang HL, et al. Carboxyamido-triazole inhibits proliferation of human breast cancer cells via G(2)/M cell cycle arrest and apoptosis. Eur J Pharmacol, 2006, 538(1-3): 15-22. 被引量:1
  • 8Guo L, Ye C, Chen W, et al. Anti-inflammatory and analgesic potency of carboxyamidotriazole, a tumorostatic agent. J Pharmacol Exp Ther, 2008, 325(1): 10-16. 被引量:1
  • 9Guo L, Ye C, Hao X, et al. Carboxyamidotriazole ameliorates experimental colitis by inhibition of cytokine production, nuclear factor-κB activation, and colonic fibrosis. J Pharmacol Exp Ther, 2012 342(2):356-365. 被引量:1
  • 10Madhusudan S, Muthuramalingam SR, Braybrooke JP, et al. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. J Clin Oncol, 2005, 23(25):5950-5959. 被引量:1

同被引文献10

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部